.png)
The Newest Generation of Advanced Placental-Based Allografts
AmnioWrap allografts are Intended for Homologous use as a Protective Covering
2
AmnioWrap is a placental-based allografts comprised of unseparated amnion and chorion membranes including the intact intermediate layer. Our proprietary BioREtain process preserves the natural integrity of the tissue.
AmnioWrap allografts act as a protective covering when placed over the wound bed or surgical site.
Amniotic Tissue contains the following:
-
Collagen
-
Laminin
-
Fibronectin
-
Cytokines & Chemokines
-
Hyaluronic acid (HA)
Benefits of AmnioWrap :
-
Acts as a barrier
-
Easy to handle and conforms to the application site
Amniotic tissue contains natural antimicrobial properties.
-
Contains growth factors
-
Pro-inflammatory growth factors promote angiogenesis and fibroblast production
-
Anti-inflammatory growth factors decrease chronic and catabolic inflammation
2
2
2
2
For Surgical Applications:
Place in the surgical site as needed. Specific orientation is not necessary for internal applications.
For Topical Applications:
When placing the amnion side down, it will directly place Epithelial Growth Factor (EGF) on a partial thickness wound site. For deeper topical wounds, placing chorion side down will place Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor (FGF) directly on the wound to help stimulate vascular and fibroblast production.
Growth Factors in Amniotic Tissue:
AmnioWrap allografts are packaged dry and stored at room temperature.
-
4-year shelf-life
-
Immunologically privileged allograft tissue
2
The patented six-step BioREtain® process is gentle, minimally invasive, and preserves the natural integrity of the amniotic tissue/ components critical to the inherent wound healing process.
AmnioWrap Assortment:
Ideal for acute and chronic wound application.
(Tri-Layer — 250 microns thick)
HCPC code: Q4221
2
